Skip to main
Russian School of Oncologists
RU
Russian School of Oncologists
  • Homepage
  • Journal
  • Publications
  • Contacts
  • Homepage
  • Publications
  • bone and soft tissue tumors
  • breast cancer
  • colon cancer
  • diagnostics
  • drug treatment
  • haematology
  • head and neck cancer
  • interventional oncology
  • liver cancer
  • lung cancer
  • major achievements
  • melanoma and skin cancer
  • neurooncology
  • oncogynecology
  • oncourology
  • pathomorphology
  • radiation therapy
  • sarcoma
  • stomach cancer
  • surgery
  • Alkalinization of the tumor microenvironment: are there prospects as a therapeutic objective?

    DOI 10.31917/2303143
    A.A. Bogdanov, An.A. Bogdanov, V.M. Moiseyenko
  • Vitamin C: is there a place in anticancer treatment?

    DOI 10.31917/2303133
    I.A. Gerk, V.M. Moiseenko
  • Iron metabolIsm and ferroptosIs as a therapeutIc target

    DOI 10.31917/2303127
    V.A. Chubenko
  • Multifactorial analysis of the dependence of prescribed diagnostic test systems and purchased targeted drugs on the example of lung adenocarcinoma in St.P.

    DOI 10.31917/2302109
    D.D. Zelikova, D.S. Yurochkin, S.E. Erdni-Garyaev, A.A. Leshkevich, Z.M. Golant, D.A. Chagin, N.M. Volkov, F.V. Moiseenko, V.M. Moiseenko
  • Possibilities of intraluminal photodynamic therapy in oncology (review)

    DOI 10.31917/2302100
    A.E. Akkalaeva, V.V. Klimenko, A.A. Avanesyan, V.V. Egorenkov, A.A. Bogdanov, V.M. Moiseyenko
  • The emerging field of checkpoint inhibitors

    DOI 10.31917/2302093
    V.A. Chubenko
  • Biomarkers predicting the effect of immunotherapy: what you need to know in practice?

    DOI 10.31917/2302081
    A.M. Konstantinova
  • What should we consider besides immune checkpoint drugs on the way to improvement of the efficacy?

    DOI 10.31917/2302072
    F.V. Moiseenko
  • Immunologic aspects of tumor biology

    DOI 10.31917/2302063
    N.M. Volkov
  • The most important results of clinical trials for breast cancer systemic therapy in 2021

    DOI 10.31917/2301009
    S.A. Tjulandin, М.В. Stenina, М.А. Frolova
  • Advances in fundamental oncology: the year 2021 update

    DOI 10.31917/2301001
    E.N. Imyanitov
  • Assessment of the quality of life of breast cancer patients after various types of surgical interventions

    DOI 10.31917/2204298
    М.А. Monogarova, Е.М. Bit-Sava, М.G. Kurbanova, А.О. Damenia, V.M. Moiseenko
  • Possibilities of intraoperative radiation therapy in the treatment of breast cancer patients

    DOI 10.31917/2204291
    Е.М. Bit-Sava, L.A. Gor, S.B. Bakhovadinova, М.А. Monogarova, М.G. Kurbanova, А.О. Damenia, А.М. Khabicheva, Т.S. Dzhukaeva, К.В. Mikhail, А.S. Zhurov, V.M. Moiseenko
  • The role of stereotaxic body radiotherapy (sbrt) in the treatment of patients with distant metastases

    DOI 10.31917/2204282
    N.V. Dengina
  • What is the role of radiotherapy for management of soft tissue and bone sarconas?

    DOI 10.31917/2204267
    T.M. Sharabura
  • Operation or systemic therapy in case of resectable metastases ?

    DOI 10.31917/2204255
    E.V. Levchenko
  • Neoadjuvant anti PD-1 / PD-L1 immune checkpoint inhibitors in locall y advanced gastric cancer with microsatellite insta bility

    DOI 10.31917/2204244
    A.Y. Navmatulya, V.A. Chubenko, S.A. Savchuk, F.R. Almukhametova, P.Y. Tsuprun, A.I. Kuznetsov, G.S. Inusilaev, V.A. Heinstein, K.V. Shelekhova, Е.М. Zykov, B.I. Miroshnikov, V.M. Moiseenko
  • Choosing the stage of treatment in patients with advanced forms of ovarian cancer

    DOI 10.31917/2204229
    V.V. Saevets, E.A. Ulrich, D.M. Rostovcev, A.Yu. Shamanova, А.A. Mukhin, S.I. Samodurov, А.V. Taratonov, Е.S. Glazyrina
  • Therapeutic targets of the tumor metabolism

    DOI 10.31917/2203183
    V.A. Chubenko
  • Acid-base balance in the regulation of tumor growth: value for the clinicians

    DOI 10.31917/2203193
    A.A. Bogdanov, An.A. Bogdanov
  • ← Previous Page
  • Next Page →
Russian School of Oncologists
Email
info@practical-oncology.ru
Subscribe

Exclusive rights to publish materials published on the site, belongs to the ANO "Patriotic School of Oncologists".

Any replication and publication in the media without the consent of the copyright owner is prohibited.

ANO "Patriotic School of Oncologists" thanks for sponsorship and website optimization: